Edwards Lifesciences Lifts 2026 Constant-Currency Sales-Growth Outlook to About 11.5%

The company also raised its TAVR growth range and projected TMTT sales of $780 million to $790 million.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.